DIACEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104 GBX | +1.46% |
|
+6.67% | +19.54% |
| Apr. 02 | Roadside shares suspended; Adnams looks for funds | AN |
| Mar. 21 | Diaceutics upgrades diagnositc commercialisation platform, DXRX | AN |
Evolution of the average Target Price on Diaceutics PLC
Price target over the last 5 years
History of analyst recommendation changes
463f8ed2cfb0e45.DkihXUnuBo1GxtrAIcd9PgF3VBcnVqeECkbkugjP5v0.Zj_lJWS0RNgHhbP5ErAJREpDIE8VZ8PzPyGhzmW_p5ZJF8s3fYRM-xGDuQ~1532ab4649a009884cc4b37e066eb754
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.04
GBP
Average target price
1.666
GBP
Spread / Average Target
+60.19%
High Price Target
2
GBP
Spread / Highest target
+92.31%
Low Price Target
1.45
GBP
Spread / Lowest Target
+39.42%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- DXRX Stock
- Consensus Diaceutics PLC